Jason Senensky (@ChapTwelveCap) header
Jason Senensky (@ChapTwelveCap) profile picture

Canadian small and microcaps.

Toronto
Joined April 2019
Photo by Jason Senensky (@ChapTwelveCap)Photo by Jason Senensky (@ChapTwelveCap)Photo by Jason Senensky (@ChapTwelveCap)Photo by Jason Senensky (@ChapTwelveCap)Photo by Jason Senensky (@ChapTwelveCap)Photo by Jason Senensky (@ChapTwelveCap)Photo by Jason Senensky (@ChapTwelveCap)Photo by Jason Senensky (@ChapTwelveCap)Photo by Jason Senensky (@ChapTwelveCap)Photo by Jason Senensky (@ChapTwelveCap)
Congrats @SachaPeter! The Canadian finance blogosphere will not be the same without you. divestor.com/?p=12540
1
1
8
836
Looking forward to this!
The speaker and stock pitch session coming together nicely for @PlanetMicroCap Toronto! @verdadcap @Stocks_Stones @RyanIrvine75 @ChapTwelveCap @IFGerryWimmer and will add a few more to the main stage shortly Register: meetmax.com/sched/event_1368…
1
8
1,255
Jason Senensky retweeted
Initial Lineup of Speakers and Stock Pitches include (more to follow): - Keynote Presentation hosted by Dan Rasmussen, Verdad Advisers @verdadcap - Keynote Q&A hosted by Jeffrey Tory, Chair, Partner, Director, Portfolio Manager at Pembroke Management @Pembroke1968 with Brad Bourne, President and CEO at Firan Technology Group Corporation $FTG.TO $FTGFF - Mathieu Martin, Portfolio Manager, Rivemont MicroCap Fund @Stocks_Stones - Jesse Gamble, Senior Vice President & Portfolio Manager at Donville Kent Asset Management @DonvilleKent - Jason Senensky, Investor & Writer at Chapter Twelve Capital @ChapTwelveCap - Ryan Irvine, President & CEO at Keystone Financial @RyanIrvine75 - Sharon Wang, Senior Investment Analyst at PenderFund Capital Management - Nicholas Cortellucci, Co-Founder & Equity Research Analyst @Atrium_Research
Planet MicroCap Toronto 2026 - First 60+ Companies, Speakers & Sponsors The lineup for @PlanetMicroCap Toronto 2026 is taking shape - we've just confirmed our first 60+ companies, speakers, and sponsors, and interest is picking up fast. More companies and attendees are being added weekly, and capacity is limited. If you’re serious about microcaps, this is where you need to be. POST: planetmicrocap.com/planet-mi… REGISTER: meetmax.com/sched/event_1368…
5
6
1
23
19,074
$XX.V posted strong March-quarter and FY26 results last week. Q4 rev +12% Y-Y, led by +35% in recurring rev. Gross margin +950 bps Y-Y to 45.2%, while adj EBITDA +77% Y-Y despite elevated year-end expenses and investment in growth initiatives. Mgmt remains highly bullish on MAST. Avante now has 29 units deployed, with 18 additional on order for delivery within four weeks. Recent traction includes Target Park, law enforcement, events and paid international pilots, with opportunities developing across Europe and Africa. Mgmt expects its traditional security operations to grow 10–15% annually, supplemented by rapid growth from NSSG and MAST. It also expects gross margin and adj EBITDA margin to improve as higher-margin products scale and operating efficiencies increase. Even after the recent stock appreciation, $XX.V trades at roughly 1.0x consensus NTM revenue and 13.5x NTM adjusted EBITDA. I think this remains an attractive valuation considering strong recurring revenue growth, margin expansion and meaningful upside if MAST converts its pipeline into recurring deployments. youtube.com/watch?v=jkpKDbJe…
3
1
10
2,189
$XX.V Avante announces its first major commercial agreement for MAST, with Target Park Group, which has 700+ parking locations across Canada and the U.S. MAST will serve as the primary security layer across select above-ground lots, with potential future modules including vehicle ID, real-time lot monitoring and customer access. Even at 100 locations, assuming only $2,500/month per unit before any technology add-ons, that would equal $3M of annual recurring revenue. More importantly, this gives real commercial validation to management’s bullish outlook for MAST. avantecorp.ca/avante-announc…
4
1
11
1,874
$PHA.v filed for CCAA today. This is the second total loss I have had on a stock in my career. It's important to learn from mistakes and maybe even celebrate them. It probably doesn't make sense to celebrate the mistake itself, but the lessons learned from the mistake. Here are my lessons from $PHA.v: 1. Don't buy highly levered lottery tickets. Period. Period. 2. If you forget #1 and buy a highly levered lottery ticket absolutely never add to the position if things are progressing worse than expected. The best course of action if developments disappoint even modestly is to sell immediately. No exceptions. 3. Management in these sorts of dicey situations is likely to be overly optimistic. You should always by default assume over-optimism on the part of the management of publicly traded companies, but this is especially so for companies experiencing financial distress. To even be realistic in these cases might be to admit defeat, and so there is strong incentive to paint a scenario where the lenders are repaid and the equity has value - to buy more time and keep the window open for additional funding. Management may also be reluctant to crystallize the financial and psychological defeat for themselves, especially so with founder/family-led businesses. I applied this lesson by selling my shares in $DII/b.to earlier this year.
1
8
816
Jason Senensky retweeted
The biggest lessons I've learned in my journey around money
2
31
2
285
11,469
Jason Senensky retweeted
Just dropped! @MicroCapClub Business Breakdown: @ChapTwelveCap, private investor, and I sit down CareRx Corporation’s $CRRX.TO President and CEO, Puneet Khanna, and Suzanne Brand, CPA, CA, CFO. CareRx delivers prescriptions to long-term care and retirement homes across five provinces, with provincial governments as the primary payer, and 92,000 residents currently under contract. This discussion took place live on May 19th, 2026, on the MicroCapClub Community. Join MicroCapClub and unlock the ability to listen and participate live in these discussions - microcapclub.com/#join In this Business Breakdown, Puneet and Suzanne cover the hub-and-spoke automation model CareRx is piloting, centralizing high-volume robotic filling to expand capacity without replicating expensive robotics at every location, the Ontario capitation fee situation and what the removal of step-down language means for the company's revenue floor, why bed count has been flat for four years and when they expect growth to resume, and how they're approaching M&A after doing prior deals at two to six times EBITDA. ✉️ Share your feedback - [email protected] ✉️ David’s X (Twitter) - teapawt.net/Valuehunte Chapters 00:00 Introduction to CareRx and Leadership Backgrounds 04:31 Understanding CareRx's Unique Business Model 07:15 Market Dynamics and Growth Opportunities 10:35 Operational Excellence and Technology Integration 13:27 Financial Performance and Capital Priorities 16:37 The CareRx Advantage and Competitive Landscape 19:58 Technology's Role in Scaling Operations 22:50 Hub and Spoke Model Implementation 25:41 Challenges in Bed Count and Market Growth 28:36 Future Outlook and Strategic Growth Plans 37:48 Regional Competition and Market Dynamics 40:39 Margin Outlook and Future Strategies 43:56 M&A Opportunities and Strategic Growth 46:34 Government Relations and Funding Outlook 51:49 Valuation and Integration in M&A 56:46 Internal Priorities and Misunderstandings 01:00:30 Future Growth and Internationalization Opportunities
1
1
6
1,130
Jason Senensky retweeted
I know Jays suck right now, but I built this anyway: jays.baby It's a daily stats panel that uses Fangraphs, MLB Stats and Savant data to show a ton of interesting information. I'm constantly adding new things too. I made this for the people, so RTs appreciated.
121
409
23
1,965
306,202
I once heard Tiger Woods say he stayed motivated even when his swing was a total mess because you never know when one small adjustment makes everything click. That idea extends well beyond sports. If you believe a single conversation, idea, meeting, or moment can dramatically change your trajectory for the better, you begin to operate in a more optimal state. It’s not delusional, it’s how reality actually works. This way of thinking was non-intuitive for me, but once I adopted it, I found it hugely beneficial.
15
267
7
2,254
96,813
Wanted to post this here in case there was any misunderstanding about @AlderLaneEggs bet between Cliff Sosin (@CliffordSosin) and myself. Here it is directly from Marc's mouth: 1) Serves breakfast, lunch, and dinner in a dress. 2) Buys me a Cobra. <$40 away now.
Three years ago, Marc Cohodes (@AlderLaneEggs) said he would buy me a brand new Ford super car if Carvana $CVNA hit $500 by 2027. Oh, and that he would cook breakfast, lunch, and dinner for @CliffordSosin and myself while wearing a dress. I am $50 away from that happening.
20
10
5
154
116,428
$DBO.TO $DBOXF D-BOX Active Screens & Royalties VS Box Office Numbers Quarterly Trend Can the royalties continue on this trend? Have they decoupled from the Box Office Numbers?
1
2
1
39
8,018
🟢🟡🔴 The Good, the Bad, and the Ugly (November 2025) Welcome to your monthly recap of the Canadian microcap market! November is always busy in our world, as most companies report third-quarter earnings. And we know that financial results in microcaps can create wild swings in share prices. That should make for an interesting review today! Before we get started, I’ll highlight two M&A announcements this past month: TRUBAR $TRBR.V, a better-for-you snacking company, announced its acquisition by ETI Gida, a Turkish strategic acquirer, for $201 million or a 64% premium to the last closing share price. Two days later, Thunderbird Entertainment $TBRD.V also announced its acquisition. The strategic acquirer was another Canadian microcap company, Blue Ant Media $BAMI.TO. The premium was 50% above the last closing share price and will be paid in a mix of cash and shares. Now let’s dive into the monthly highlights. If you're new, the concept of the Good, the Bad, and the Ugly is simple. I feature the news that caught my attention during the previous month after skimming through all the press releases on the Canadian market. Every press release, every single day! THE GOOD ✅ The most impressive financial report I’ve seen in November came out of D-BOX Technologies $DBO.TO $DBOXF, a Rivemont MicroCap Fund portfolio holding. The maker of motion-enabled cinema seats reported record quarterly royalties, record total revenues, a record adjusted EBITDA and a record net profit. The company’s total revenues were up 33% YoY, with royalties (the highest-margin revenue item) growing 40% and net income rising 123%. The stock jumped as much as 30% the following day and ended the month up 53%. Despite the share price increase, the stock still trades at roughly 8 times earnings based on these quarterly results, annualized. That’s how good the results were! ✅ Another notable financial report came out of Caldwell Partners International $CWL.TO, a tech-enabled talent acquisition firm. Following two years of revenue declines in what was apparently a challenging macro environment for hiring, Caldwell posted stellar fiscal Q4 2025 results. Quarterly and full-year revenues were up 42% and 19%, respectively. Earnings per share came in at $0.05 for the quarter and $0.087 for the year, which compares quite favourably with the prevailing share price of $0.67. The stock soared 42% in the days following the news. ✅ In the special situation category, one piece of news caught my attention. Maritime Launch Services $MAXQ, a commercial space company developing Spaceport Nova Scotia, announced a $10 million strategic investment from MDA Space $MDA.TO, a $3 billion TSX-listed company. The investment was made at $0.223 per share, when Maritime’s stock was trading at $0.15, representing a 49% premium. This announcement combined validation from a strategic industry partner, a crucial capital injection for a pre-revenue company, and a clear indication that the prevailing share price was undervalued. That potent mix propelled the stock higher by as much as 233% over the following days! Arguably, the news sparked significant speculation, and the stock overshot to the upside. Even after settling back down, MAXQ ended the month up 53%, a solid return for shareholders! THE BAD ❌ I said in the introduction that earnings can create wild swings in share prices. Sometimes, it doesn’t take much for the sentiment to shift big time. For example, Zoomd Technologies $ZOMD.V, a favourite of the microcap crowd this past year, reported a 3% year-over-year decline in revenues in its third quarter. Even if the revenue decline came with improved gross margins and profitability, the CEO’s comments about the industry’s changing landscape created near-term uncertainty for investors. The fundamentals didn’t change all that much, but the narrative shifted. Zoomd’s stock experienced a brutal 26% decline the following day. In the same vein, NTG Clarity Networks $NCI.V, another recent investor favourite, released quarterly results showing strong top-line growth (+ 42%) but a slight decline in profitability (-7%). The company had to reduce its yearly EBITDA guidance from an 18% margin to a 14% margin (at the midpoints) due to increased growth investments this year. The stock declined as much as 40% the next day. Fortunately, NCI had recouped most of its losses by the end of the month. ❌ It’s never a good sign when a company has to file its financial statements late. Typically, you tend to see such occurrences in nanocaps with questionable business models. When it happens to a $600 million market cap TSX-listed company, the outcome can be brutal. A day before the filing deadline, Ag Growth International $AFN.TO announced that it would be unable to file its financials because its auditor needed more time to finalize the accounting treatment of the company’s Brazilian operations. Additionally, in light of uncertainty regarding third-quarter results, the company withdrew its previously issued EBITDA guidance for the year. The stock cratered 40% the following day. That’s over $240 million in market cap evaporated on a late filing… ouch! ❌ A weird situation happened with Hydreight Technologies $NURS.V. The company published its financial results on a Wednesday night with an earnings call scheduled for Friday afternoon. In between, the stock declined by about 10%, which isn’t unusual for a microcap stock. But if you look carefully at the stock chart (below), you can see that the stock started to sell off hard right in the middle of the earnings call on Friday afternoon. Apparently, the management team got confused during the discussion of some KPIs, and investors concluded there had been a dramatic slowdown in the business after the end of the quarter. The stock finished the day down 27%. A couple of days later, the company issued a press release to set the record straight and clarify the KPIs, which led to a 28% rally in the shares. The market cap literally swung by over $45 million in each direction based on confusing statements on the earnings call. That’s how crucial public communications can be! THE UGLY ⚠️ I typically see a couple of microcap bankruptcies every month, but the pace picked up in November. Multiple companies entered insolvency proceedings, including Exro Technologies $EXRO.TO, Voxtur Analytics $VXTR.V, Hill $HILL.V, and Tilt Holdings $TILT. Additionally, we’ll have to say a final goodbye to Deveron $FARM.V. The company will complete a distressed asset sale and return a mere $0.0067 per share to common shareholders, representing a 99.3% loss from its 2021 peak. ⚠️ Simply Solventless Concentrates $HASH.V, which I highlighted previously due to issues with audit delays and changes to revenue recognition policies, had regained some investors’ trust (not mine, though) after showing decent progress in its first two quarters of 2025. However, when the company published third-quarter results showing a 43% sequential revenue decline and a net loss, the stock imploded again, losing as much as 53% in two days. The company attributed the decline to significant sales to partners in the second quarter that did not recur in the third quarter but could recur in subsequent quarters. It is terribly challenging for me to gain any visibility into what is happening at SSC. This story always has a new twist… ⚠️ Venzee Technologies $VENZ.V announced the acquisition of Jasper PIM from Digital Commerce Payments (“DCP”). The Jasper business used to be a public company on its own, going public in 2022 under the name Jasper Commerce $JPIM.V at a $29 million valuation. It only took two and a half years for Jasper to be run into the ground. Ultimately, Jasper completed a distressed asset sale to DCP, resulting in a complete loss for shareholders. DCP is now flipping the asset into Venzee, another public vehicle, for a little more than double what they paid last year. If you haven’t lost money with this one the first time, here’s another chance to invest. Perhaps it will turn out differently this time! Who knows? That’s all I have for you this month! I hope you enjoyed it. If you like the content, please help spread the word by sharing it with like-minded investors. You can also sign up to my free newsletter (link in bio) so you don't miss the next posts. Thank you for reading!
3
8
2
32
8,217
The Compass Made of Wounds My pain is my compass a trembling needle always pointing toward the place I’m afraid to touch. And though healing waits like a doorway I won’t cross, I still circle it scared to enter, scared to stay lost.
2
7
612
Jason Senensky retweeted
It seems that the older and more accomplished investors get, the more open they become in acknowledging the role of phenomena that transcend explicit knowledge. 🧵 Last year, Buffett attributed one of his most lucrative purchases ever - $AAPL - to his personal experience of “apperceptive mass”. Druckenmiller, 20 years into his staggering success, had the comfort to describe how he would notice something "not acting right" in his daily review of 272 charts - or in his real-time P&L - and completely change his position. And after he stopped actively managing Quantum, we’ve got the market animal in Soros who shared how he would bail on billion dollar investments on account of a fresh back ache.
1
1
1
11
1,962
A truth about investing that is widely known by anyone that's spent more than a few weeks in the industry but rarely acknowledged: Decision making almost always comes down to emotional comfort rather than logic / information. Volume / speed of info processing is irrelevant.
3
1
67
7,773
Jason Senensky retweeted
Replying to @ignatius_solon
Billionaire activist man
105
102
39
1,829
225,916